Flash FinanceUS
Pre-market S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Elanco (ELAN)

Elanco signs $350 million incremental term loan maturing August 2031

Neutral Impact 3 of 5 financing Written later

Elanco Animal Health entered an incremental assumption agreement under its existing senior secured credit facility, adding a new $350 million term loan. Proceeds will repay outstanding obligations under an existing term loan and fund general corporate purposes. The filing says the new facility's interest rate and repayment terms are generally consistent with the existing term loan.

Key points

  • New incremental term facility totals $350,000,000 under the Credit Agreement dated August 1, 2020
  • Proceeds will repay outstanding obligations under an existing term loan and for general corporate purposes
  • Facility matures on August 13, 2031; terms generally consistent with the existing term loan
  • Lenders include Farm Credit Mid-America, PCA as incremental term lender and Goldman Sachs Bank USA as term facility agent

The filing

CompanyElanco (ELAN)
Form8-K, current report
Filed with the SECAug 13, 2024, 4:32 PM ET
Accession number0001104659-24-089000

Items reported: 1.01 Material Definitive Agreement2.03 New Direct Financial Obligation

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:12 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 13, 2024.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.